![](/img/cover-not-exists.png)
A multicenter randomized phase III study comparing paclitaxel-cisplatin-etoposide (TEP) versus cisplatin-etoposide (EP) as front-line treatment in patients with small cell lung cancer (SCLC)
Mavroudis, D, Papadakis, E, Veslemes, M, Agelidou, M, Tsiafaki, X, Agelidou, G, Pavlakos, G, Anagnostopoulou, O, Giannakakis, Th, Ziras, N, Bania, M, Lambrakis, Ch, Kouroussis, Ch, Samonis, G, BachlitVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80091-4
Date:
September, 2000
File:
PDF, 103 KB
english, 2000